Intracellular expression of RNA transcripts complementary to the human immunodeficiency virus type 1 gag gene inhibits viral replication in human CD4+ lymphocytes
- PMID: 8971008
- PMCID: PMC190976
- DOI: 10.1128/JVI.70.12.8792-8800.1996
Intracellular expression of RNA transcripts complementary to the human immunodeficiency virus type 1 gag gene inhibits viral replication in human CD4+ lymphocytes
Abstract
Intracellular expression of antisense transcripts was evaluated for its potential to interfere with human immunodeficiency virus type 1 (HIV-1) replication. Retroviral vectors encoding HIV-1 psi-gag complementary sequences downstream of a selectable gene (neo, puromycin gene, or Lyt2 gene) were stable and yielded high titers. Human CEMSS T cells were transduced with amphotropic retroviral vectors to express RNA complementary to the psi-gag sequence of HIV-1. Replication of laboratory-adapted HIV-1 strains was inhibited by more than 1 order of magnitude (log10) in these transduced cells even at high inoculation doses (4 x 10(4) 50% tissue culture infective doses). Antisense-mediated anti-HIV efficacy was further demonstrated by survival of CD4+ cells in these cultures relative to controls. The level of anti-HIV-1 activity of the psi-gag antisense sequence correlated with the length of the antisense transcript. Maximal anti-HIV efficacy was observed with complementary sequence more than 1,000 nucleotides long, whereas transcripts less than 400 nucleotides long failed to inhibit HIV-1 replication. Expression of psi-gag antisense RNA also reduced HIV-1 JR-CSF replication 10-fold in primary CD4+ lymphocytes. These results obtained with a T-cell line and primary peripheral blood lymphocytes indicate the potential of long antisense RNAs as an efficient anti-HIV-1 therapeutic agent for gene therapy.
Similar articles
-
Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.J Virol. 1998 Mar;72(3):1894-901. doi: 10.1128/JVI.72.3.1894-1901.1998. J Virol. 1998. PMID: 9499041 Free PMC article.
-
A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.Front Biosci. 2002 Feb 1;7:a15-28. doi: 10.2741/ding. Front Biosci. 2002. PMID: 11815282
-
Inhibition of infectious human immunodeficiency virus type 1 virions via lentiviral vector encoded short antisense RNAs.Oligonucleotides. 2006 Winter;16(4):287-95. doi: 10.1089/oli.2006.16.287. Oligonucleotides. 2006. PMID: 17155905
-
Retroviral Antisense Transcripts and Genes: 33 Years after First Predicted, a Silent Retroviral Revolution?Viruses. 2021 Nov 4;13(11):2221. doi: 10.3390/v13112221. Viruses. 2021. PMID: 34835027 Free PMC article. Review.
-
Molecular strategies to inhibit HIV-1 replication.Retrovirology. 2005 Feb 16;2:10. doi: 10.1186/1742-4690-2-10. Retrovirology. 2005. PMID: 15715913 Free PMC article. Review.
Cited by
-
Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.J Virol. 1998 Mar;72(3):1894-901. doi: 10.1128/JVI.72.3.1894-1901.1998. J Virol. 1998. PMID: 9499041 Free PMC article.
-
Co-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication.Nucleic Acids Res. 1998 Jul 1;26(13):3270-8. doi: 10.1093/nar/26.13.3270. Nucleic Acids Res. 1998. PMID: 9628929 Free PMC article.
-
Is gene therapy a good therapeutic approach for HIV-positive patients?Genet Vaccines Ther. 2007 Feb 14;5:5. doi: 10.1186/1479-0556-5-5. Genet Vaccines Ther. 2007. PMID: 17300725 Free PMC article.
-
Efficient inhibition of HIV-1 replication by an artificial polycistronic miRNA construct.Virol J. 2012 Jun 18;9:118. doi: 10.1186/1743-422X-9-118. Virol J. 2012. PMID: 22709537 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials